Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Nicky Mehtani, MD, MPH

Photo of Nicky Mehtani, MD, MPH
Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
ORCID ORCID Icon0000-0003-4277-6889 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California, San FranciscoPostdoc06/2024Addiction Research
    California Institute of Integral StudiesCertificate12/2021Psychedelic Therapy & Research
    University of California, San FranciscoClinical Fellowship06/2020Addiction Medicine
    Johns Hopkins HospitalResidency06/2019Internal Medicine - Urban Health
    Johns Hopkins School of MedicineMD05/2016Medicine
    Johns Hopkins School of Public HealthMPH05/2015Epidemiology
    Rice UniversityBA05/2011Biochemistry, Global Health
    Collapse awards and honors
    UCSF Dean's Office2025Population Health & Health Equity Scholar
    UCSF Clinical & Translational Science Institute2024KL2 Career Development Award (NIH-NCATS)
    UCSF Center for AIDS Prevention Sciences2024CAPS Innovative Award (NIH-NIMH)
    Brain & Behavior Research Foundation2023Young Investigator Grant
    California HIV/AIDS Research Program2023Early Stage Investigator Pilot Award
    UCSF Department of Psychiatry 2022T32 Postdoctoral Fellowship (NIH-NIDA)
    American Academy of Addiction Psychiatry2019REACH Fellowship (SAMHSA)
    Johns Hopkins School of Medicine2016David M. Levine Research Award
    Johns Hopkins School of Public Health2015MPH Best Overall Capstone Award
    Rice University2015Linda Faye Williams Social Justice Alumni Award
    Johns Hopkins School of Public Health2014Watt/Hansell Scholarship
    Lancet Editorial Board2012Wakley Prize

    Collapse Overview 
    Collapse overview
    Nicky Mehtani, MD, MPH is an Assistant Professor in the UCSF Division of General Internal Medicine at San Francisco General Hospital. Her research focuses on the use of psychedelic therapies to treat addiction and psychological trauma, with an emphasis on expanding access to these emerging treatments for medically and socially complex populations. She is also a faculty affiliate of UCSF Neuroscape, the Philip R. Lee Institute for Health Policy Studies, and the San Francisco Department of Public Health’s (SFDPH) Center on Substance Use and Health.

    Clinically, Dr. Mehtani specializes in Addiction and HIV Medicine, providing care at the SFDPH Maria X. Martinez Health Resource Center, a low-barrier clinic serving people experiencing homelessness and unstable housing. In this role, she has led the implementation of long-acting injectable antiretroviral medications for HIV treatment and prevention.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders. J Psychoactive Drugs. 2025 Nov 10; 1-10. Mehtani NJ, Mian MN, Agin-Liebes G, Coker AR, Huebner C, Anderson BT, Mitchell JM. PMID: 41214462.
      View in: PubMed   Mentions:
    2. Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks. BMJ Open. 2025 Aug 24; 15(8):e100775. Mehtani NJ, Anderson BT, Alexander I, Hendricks PS, Mitchell JM, Coffin PO, Johnson MO. PMID: 40850924; PMCID: PMC12382537.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    3. HIV Viral Suppression With Unintentional Lenacapavir Monotherapy in Adherence-Challenged Patients: A Case Series. Open Forum Infect Dis. 2025 Jun; 12(6):ofaf330. Mehtani NJ, Grochowski J, Chimezie A, Strough A, Strieff S, Gandhi M. PMID: 40568009; PMCID: PMC12188974.
      View in: PubMed   Mentions:
    4. A systematic review of income and education reporting in psychedelic clinical trials. Nature Mental Health. 2025; 3(5):567-74. Grossman DH, Madden KR, Mehtani NJ, Anderson BT, Davis LL, Mitchell JM, Hendricks PS.
    5. On Minimizing Risk and Harm in the Use of Psychedelics. Psychiatr Res Clin Pract. 2025; 7(1):4-8. Evans J, Aixalà M, Anderson BT, Brennan W, Bremler R, Breeksema JJ, Burback L, Calder AE, Carhart-Harris RL, Cheung K, Devenot N, Gorman I, Gren J, Hendricks PS, Holoyda B, Jacobs E, Krecké J, Kruger DJ, Luke D, Majic T, McGuire AL, Mehtani NJ, Mathai DS, Nash K, Noorani T, Palitsky R, Robinson OC, Simonsson O, Stahre E, van Elk M, Yaden DB. PMID: 40171068; PMCID: PMC11956720.
      View in: PubMed   Mentions:
    6. A Review of Implementation Strategies to Enhance PrEP Delivery for People Experiencing Housing Insecurity: Advancing a Multifaceted High-Touch, Low-Barrier Approach. Curr HIV/AIDS Rep. 2024 Nov 22; 22(1):4. Velloza J, Mehtani NJ, Hickey MD, Imbert E, Appa A, Riley ED. PMID: 39576385; PMCID: PMC11584499.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    7. Psilocybin-assisted therapy and HIV-related shame. Sci Rep. 2024 08 02; 14(1):17919. Mehtani NJ, Johnson MO, Hendricks PS, Mitchell J, Anderson BT. PMID: 39095420; PMCID: PMC11297300.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Feasibility of Implementing a Low-Barrier Long-Acting Injectable Antiretroviral Program for HIV Treatment and Prevention for People Experiencing Homelessness. J Acquir Immune Defic Syndr. 2024 05 01; 96(1):61-67. Mehtani NJ, Strough A, Strieff S, Zevin B, Eveland J, Riley ED, Gandhi M. PMID: 38346426; PMCID: PMC11009050.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    9. Facing a Tsunami: Methamphetamine Heart Failure Demands Novel Approaches. JACC Adv. 2024 Jul; 3(7):100838. Walker SL, Mehtani NJ, Parikh NI. PMID: 39130028; PMCID: PMC11312028.
      View in: PubMed   Mentions: 1  
    10. Psychedelics in Addiction Treatment-Navigating a Sociopolitical Rift. JAMA Neurol. 2024 Jan 16. Mehtani NJ, Anderson BT, Mitchell JM. PMID: 38227310.
      View in: PubMed   Mentions: 1     Fields:    
    11. Housing Instability Associated with Return to Stimulant Use among Previously Abstaining Women. Int J Environ Res Public Health. 2023 09 26; 20(19). Mehtani NJ, Chuku CC, Meacham MC, Vittinghoff E, Dilworth SE, Riley ED. PMID: 37835100; PMCID: PMC10572661.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics. J Psychoactive Drugs. 2024 Apr-Jun; 56(2):206-210. Thomas KL, Jesse R, Mehtani NJ, Mitchell JM, Anderson BT. PMID: 37061961.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Understanding HIV Pre-Exposure Prophylaxis Questions of U.S. Health Care Providers: Unique Perspectives from the PrEPline Clinical Teleconsultation Service. Telemed J E Health. 2023 03; 29(3):376-383. Saberi P, Mehtani NJ, Sayegh A, Camp CE, Chu C. PMID: 35802493; PMCID: PMC10024264.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    14. Perceptions on navigating ACGME-accredited addiction psychiatry fellowship program websites: A thematic analysis across a race- and gender-diverse pool of potential applicants. Subst Abus. 2022; 43(1):834-840. Abrams MP, Jackson DS, Aneke-Gratia A, Kohler AE, Mehtani N, Jordan A. PMID: 35142262.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Infectious Diseases Learning Unit: Understanding Advances in the Treatment of Latent Tuberculosis Infection Among People With Human Immunodeficiency Virus. Open Forum Infect Dis. 2021 Aug; 8(8):ofab319. Mehtani NJ, Puryear S, Pham P, Dooley KE, Shah M. PMID: 34395707; PMCID: PMC8361237.
      View in: PubMed   Mentions: 2  
    16. Successful implementation of managed alcohol programs in the San Francisco Bay Area during the COVID-19 crisis. Subst Abus. 2021; 42(2):140-147. Ristau J, Mehtani N, Gomez S, Nance M, Keller D, Surlyn C, Eveland J, Smith-Bernardin S. PMID: 33848451.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsPHPublic Health
    17. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management. Subst Abus. 2021; 42(2):205-212. Mehtani NJ, Ristau JT, Snyder H, Surlyn C, Eveland J, Smith-Bernardin S, Knight KR. PMID: 33684331.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsPHPublic Health
    18. COVID-19: Broadening the horizons of U.S. harm reduction practices through managed alcohol programs. J Subst Abuse Treat. 2021 05; 124:108225. Mehtani NJ, Ristau JT, Eveland J. PMID: 33293179; PMCID: PMC9758623.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    19. Immunogenicity and Safety of the Measles Vaccine in HIV-Infected Children: An Updated Systematic Review. Am J Epidemiol. 2019 12 31; 188(12):2240-2251. Mehtani NJ, Rosman L, Moss WJ. PMID: 31210268.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Development and Validation of HIV-ASSIST, an Online, Educational, Clinical Decision Support Tool to Guide Patient-Centered ARV Regimen Selection. J Acquir Immune Defic Syndr. 2019 10 01; 82(2):188-194. Maddali MV, Mehtani NJ, Converse C, Kapoor S, Pham P, Li JZ, Shah M. PMID: 31513553.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    21. Elevated highly sensitive C-reactive protein and d-dimer levels are associated with food insecurity among people living with HIV in Pune, India. Public Health Nutr. 2019 08; 22(11):2022-2029. Patil S, Kadam D, Mehtani N, Sangle S, Marbaniang I, Kulkarni V, Shere D, Deshpande P, Dhumal G, Suryavanshi N, Gupte N, Bollinger R, DeLuca A, Nevrekar N, Menon P, Kawade R, Patil M, Gupta A, Mave V. PMID: 30827288; PMCID: PMC6561786.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Three Years Post-Affordable Care Act Sexually Transmitted Disease Clinics Remain Critical Among Vulnerable Populations. Am J Prev Med. 2018 07; 55(1):111-114. Mehtani NJ, Schumacher CM, Johnsen LE, Greenbaum A, Chaulk CP, Ghanem KG, Jennings JM, Page KR. PMID: 29776778.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Continued Importance of Sexually Transmitted Disease Clinics in the Era of the Affordable Care Act. Am J Prev Med. 2016 09; 51(3):364-7. Mehtani NJ, Schumacher CM, Johnsen LE, Khaldun JS, Chaulk CP, Ghanem KG, Jennings JM, Page KR. PMID: 27242080; PMCID: PMC4992609.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    24. The Shift: When People Become Patients. Md Med. 2016; 17(1):29-31. DesRosiers T, Mehtani N, Gornet M, Zuo SW, Hrdina R, Vandiver AR, Purvis T, LaVigne A, Dichoso T, Towle DW, Staiano P, Kapoor S, Rogers D, Pham A, Lange R, Fan C, Shrock C, Maredia H, Doong J, Song A. PMID: 27443129.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. The measuring cup. Lancet. 2013 Dec 21; 382(9910):2112-3. Mehtani N. PMID: 24360388.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Nicky's Networks
    Concepts (97)
    Derived automatically from this person's publications.
    _
    Co-Authors (20)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _